Patents of Stem Cells Banned If Embryo Destroyed: EU

Europe's top court on Tuesday banned researchers from patenting any process to extract stem cells when it leads to the destruction of a human embryo.

Researchers are banned from patenting any process to extract stem cells when it leads to the destruction of a human embryo, Europe's top court said on Tuesday.

In a ruling that could affect medical research, the EU Court of Justice court said the use of human embryos "for therapeutic or diagnostic purposes which are applied to the human embryo and are useful to it is patentable."

Genetic Liver Disease can be Cured by Skin Stem Cells
An alternative to embryonic stem cell therapy that could correct a genetic mutation from a patient's own skin cell has been developed by a team of researchers

"But their use for purposes of scientific research is not patentable," the court ruled.

The EU judges were asked by the German Federal Court of Justice to provide an interpretation of a human embryo following an appeal from a German scientist, whose patent on a method to create nerve cells from human embryonic stem cells was ruled invalid.

The scientist, Oliver Bruestle, said there were already clinical applications for his invention to treat patients with Parkinson's disease.

Genetic Diseases may be Treated With Patient�s Own Stem Cells in Future
A new study published in the journal Nature has suggested that people with genetic diseases can be treated with their own cells in the future

But the Luxembourg-based court said that "a process which involves removal of a stem cell from a human embryo at the blastocyst stage, entailing the destruction of that embryo, cannot be patented."

Blastocyst is a later stage of embryonic development, almost five days after fertilisation.

Regenerating Eyes Using Stem Cells from Hair
A young scientist has used stem cells from hair follicles to treat eye surface disease has been named the winner of the Young Investigator Award by the journal Stem Cells.

Source-AFP

Milestone in Human Stem Cells
A novel technique to reprogramme human cells into stem cells has been devised by Wellcome Trust Sanger Institute researchers.